Competing on Analytics: The strategic value of analytics and MDM

Today’s high-performance organizations are making analytics a central capability in gaining sustainable advantage. These “Analytic Competitors” are those companies that have developed robust capabilities to industrialize the process of converting data into insights. MDM is a critical foundational component of a successful analytic capability. For many of today’s pharmaceutical companies, creating this capability requires significant investments in new infrastructure and transformational change in how the organization manages data and applies analytics. In order to support our clients and accelerate the rate of transformation, Accenture is investing in developing industry-specific solutions that meets basic requirements and can be further customized to each client’s needs. One of these solutions, the pharmaceutical Customer Master tool, was developed in partnership with Siperian.